We are live on ! Find out more

Astrana Health

ASTH

Market cap $1.87B

37.61 USD

-0.50

1.31%

At close Updated Aug 25, 4:00 PM EDT

Pre-market

After hours

37.61

0.00

0%

1 day

-1.31%

5 days

-5.29%

1 month

-1.52%

3 months

-2.41%

6 months

88.52%

Year to date

49.13%

1 year

25.66%

5 years

-47.75%

10 years

276.1%

About: Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

Employees: 3,000

Healthcare Medical Care Facilities

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 25%

Neutral 75%

Negative 0%

Astrana Health: 81% Full-Risk And Profitable

Astrana Health is rated a buy, trading at a 46% discount to peers despite sector-wide reserve releases clarifying earnings quality concerns. ASTH's Care Enablement platform drove G&A costs from 7.75% to 5.57% of revenue, quadrupling third-party revenue year-over-year and supporting durable profit at scale. Organic growth is driven by a mix-shift into full-risk capitation, with management projecting ongoing revenue-per-member expansion and a robust conversion pipeline.

Astrana Health: 81% Full-Risk And Profitable

Astrana Health, Inc. (ASTH) Q2 2026 Earnings Call Transcript

Astrana Health, Inc. (ASTH) Q2 2026 Earnings Call Transcript

Astrana Health, Inc. (ASTH) Q2 2026 Earnings Call Transcript

Zacks Investment Research

Astrana Health, Inc. (ASTH) Q2 Earnings Top Estimates

Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.4 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.19 per share a year ago.

Astrana Health, Inc. (ASTH) Q2 Earnings Top Estimates

Astrana Health Q2 Earnings Call Highlights

Astrana Health NASDAQ: ASTH reported second-quarter 2026 revenue of $973 million, up 49% from a year earlier, while adjusted EBITDA increased 43% to $69 million. Adjusted diluted earnings per share reached a record $0.80, up 45% year over year, as the company cited growth in value-based care arrangements, medical-cost management, Prospect Health acquisition synergies and operating leverage.

Astrana Health Q2 Earnings Call Highlights

Astrana Health, Inc. Reports Second Quarter 2026 Results

Company to Host Conference Call on Thursday, August 6, 2026, at 2:30 p.m. PT/5:30 p.m.

Astrana Health, Inc. Reports Second Quarter 2026 Results

The London Company Large Cap Vs. Russell 1000 Q2 2026 Portfolio Review

The London Company Large Cap portfolio returned 10.9% (10.7% net) during the quarter vs. a 15.1% increase in the Russell 1000 Index. ENTG was a top contributor, benefiting from improving fab utilization and accelerating AI-driven semiconductor demand. RSG declined despite another solid quarter as softer Environmental Solutions results and continued weakness in construction-related volumes weighed on investor sentiment.

The London Company Large Cap Vs. Russell 1000 Q2 2026 Portfolio Review

Diamond Hill Small Cap Fund Q2 2026 Portfolio Activity

Astrana Health outperformed as the company results have continued to demonstrate that it was not taking advantage of loopholes within Medicare coding. Magnolia Oil & Gas saw shares decline after an agreement was reached to end the war between the US and Iran and reopen the Strait of Hormuz. We initiated a position in Insteel Industries, the nation's largest manufacturer of steel wire reinforcing products for concrete construction.

Diamond Hill Small Cap Fund Q2 2026 Portfolio Activity

Astrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference Call

ALHAMBRA, Calif., July 14, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the second quarter ended June 30, 2026, after the close of the stock market on Thursday, August 6, 2026.

Astrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference Call

Astrana Health Strengthens Leadership Team to Accelerate Long-Term Growth

Names Daniel Rothman President of Physician Enterprise and Vishal Gupta Senior Vice President of Enterprise Transformation ALHAMBRA, Calif., July 13, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced the appointments of Daniel Rothman as President of Physician Enterprise and Vishal Gupta as Senior Vice President of Enterprise Transformation.

Astrana Health Strengthens Leadership Team to Accelerate Long-Term Growth

Astrana Health ACOs Deliver $120.4 Million in Gross Shared Savings in 2024 Performance Year

All Eight ACOs Achieve Net Shared Savings ALHAMBRA, Calif., July 13, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that its Accountable Care Organizations (ACOs) generated $120.4 million in gross shared savings during the 2024 performance year.

Astrana Health ACOs Deliver $120.4 Million in Gross Shared Savings in 2024 Performance Year

See News Rankings

Price charts implemented using Lightweight Charts™